ismidenon
Generic: Ismidenon
ismidenon: 1 clinical trial tracked.
ismidenon evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about ismidenon, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 1-2 Dose-escalation and Expansion Study of ST101 in Patients With Advanced Unresectable and Metastatic Solid Tumors
Primary endpoint: Dose-Limiting Toxicity (DLT)
Interventionalopen125 targetStarted 2020-07Completion 2026-1211 sites · United Kingdom, United StatesSapience Therapeutics